Description
Daxas (Roflumilast) is classified as a phosphodieterase 4 inhibitor and it works by decreasing inflammation inside the lungs. Indications include COPD (chronic obstructive pulmonary disease) and asthma. Some patients have also been treated with it for chronic bronchitis. When administered, this medicine blocks the action of the enzyme known as phosphodiesterase 4, and prevents it from causing inflammation. This in turn lowers the production of mucus and helps prevent the airways from becoming narrow, which leads to an improvement in breathing.
- Vertigo
- Sore back
- Weight loss
- Appetite reduction
- Spasms affecting the muscles
In some cases, the occurrence of severe adverse reactions which required the immediate attention of a physician have occurred. This is generally considered to be a less common occurrence. However, if it does happen, you must get medical help straight away.
Avoid driving or other dangerous tasks if you become dizzy.